Lineage Cell Therapeutics (LCTX) EPS (Weighted Average and Diluted) Growth (5y) (2020 - 2026)
Lineage Cell Therapeutics (LCTX) EPS (Weighted Average and Diluted) Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lineage Cell Therapeutics | 303.84 Mn | 239.94 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.57% |
| Sep 30, 2025 | -21.06% |
| Jun 30, 2025 | -26.58% |
| Mar 31, 2025 | 19.73% |
| Sep 30, 2024 | 28.89% |
| Jun 30, 2024 | 31.57% |
| Mar 31, 2024 | -16.36% |
| Sep 30, 2023 | -15.72% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 43.03% |
| Dec 31, 2022 | 45.78% |
| Sep 30, 2022 | -18.47% |
| Jun 30, 2022 | 18.32% |
| Mar 31, 2022 | -15.85% |
| Sep 30, 2021 | -16.72% |
| Jun 30, 2021 | -16.17% |
| Mar 31, 2021 | 44.51% |
| Sep 30, 2020 | 22.60% |
| Jun 30, 2020 | 19.73% |